» Articles » PMID: 12721940

Protection Against Group A Streptococcus by Immunization with J8-diphtheria Toxoid: Contribution of J8- and Diphtheria Toxoid-specific Antibodies to Protection

Overview
Journal J Infect Dis
Date 2003 May 2
PMID 12721940
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

A conformationally constrained, minimally conserved peptide from the M protein of group A streptococcus (GAS) has been defined. It consists of 12 amino acids from the C-repeat region within a non-M protein helix-forming sequence and is referred to as "J8." Here, we investigate the immunogenicity of a J8-diphtheria toxoid (DT) conjugate adjuvanted with the human-compatible adjuvants, SBAS2 and alum, and demonstrate that it is capable of inducing opsonic antibodies and can protect outbred mice from virulent challenge. In a range of experiments, protection correlated with the titer of J8-specific antibodies and not with the induction of J8-specific T cells. However, DT-specific antibodies (as well as J8-specific antibodies) were shown to stain the surface of fixed GAS and to be capable of opsonizing live organisms. DT may be an ideal carrier protein for J8 and other GAS peptides for GAS vaccines.

Citing Articles

A synthetic cyclic peptide for promoting antigen presentation and immune activation.

Zhang J, Madge H, Mahmoud A, Lu L, Wang W, Huang W NPJ Vaccines. 2025; 10(1):9.

PMID: 39809901 PMC: 11733015. DOI: 10.1038/s41541-024-01050-4.


Conserved molecular chaperone PrsA stimulates protective immunity against group A Streptococcus.

Lai C, Xie J, Lai M, Wu Z, Lin J, Huang Y NPJ Vaccines. 2024; 9(1):46.

PMID: 38409165 PMC: 10897429. DOI: 10.1038/s41541-024-00839-7.


Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease-streptococcal vaccine development: a national heart, lung and blood institute workshop report.

Fulurija A, Cunningham M, Korotkova N, Masterson M, Bansal G, Baker M BMJ Glob Health. 2024; 8(Suppl 9).

PMID: 38164699 PMC: 10729269. DOI: 10.1136/bmjgh-2023-013534.


: Pathogenesis and the Current Status of Vaccines.

Wang J, Ma C, Li M, Gao X, Wu H, Dong W Vaccines (Basel). 2023; 11(9).

PMID: 37766186 PMC: 10534548. DOI: 10.3390/vaccines11091510.


A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

Ozberk V, Zaman M, Lepletier A, Eskandari S, Kaden J, Mills J Nat Commun. 2023; 14(1):5963.

PMID: 37749129 PMC: 10520070. DOI: 10.1038/s41467-023-41410-7.